Globeflex Capital’s Medifast MED Stock Holding History

Globeflex Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-914	Closed	-$165K	–	522
2022 Q2	$165K	Hold	914	–	–	0.04%	341
2022 Q1	$156K	Hold	914	–	–	0.03%	360
2021 Q4	$191K	Hold	914	–	–	0.04%	358
2021 Q3	$176K	Sell	914 -5,490	-86%	-$1.35M	0.04%	343
2021 Q2	$1.81M	Buy	6,404 +15	+0.2%	+$4.07K	0.33%	92
2021 Q1	$1.35M	Hold	6,389	–	–	0.25%	133
2020 Q4	$1.25M	Sell	6,389 -105	-2%	-$18.6K	0.27%	122
2020 Q3	$1.07M	Sell	6,494 -816	-11%	-$134K	0.28%	118
2020 Q2	$1.01M	Buy	7,310 +548	+8%	+$50.3K	0.26%	127
2020 Q1	$423K	Hold	6,762	–	–	0.13%	262
2019 Q4	$741K	Sell	6,762 -261	-4%	-$25.3K	0.14%	255
2019 Q3	$728K	Hold	7,023	–	–	0.16%	219
2019 Q2	$901K	Hold	7,023	–	–	0.19%	180
2019 Q1	$896K	Buy	+7,023	New	+$891K	0.19%	183
2017 Q1	–	Sell	-10,053	Closed	-$419K	–	507
2016 Q4	$419K	Hold	10,053	–	–	0.1%	280
2016 Q3	$380K	Buy	+10,053	New	+$360K	0.1%	281
2014 Q2	–	Sell	-110	Closed	-$3K	–	650
2014 Q1	$3K	Hold	110	–	–	﹤0.01%	407
2013 Q4	$2K	Hold	110	–	–	﹤0.01%	456
2013 Q3	$2K	Sell	110 -48,331	-100%	-$1.29M	﹤0.01%	440
2013 Q2	$1.25M	Buy	+48,441	New	+$1.27M	0.17%	158

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Globeflex Capital's MED Position: Q3 2022 in Review

Globeflex Capital sold out of Medifast (MED) in Q3 2022, closing a stake of 914 shares — an estimated $165K sold.

Globeflex Capital first reported a position in MED in Q2 2013 and held it in 20 quarters. The position peaked at $1.81M in Q2 2021. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

Globeflex Capital reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
Globeflex Capital sold 914 Medifast shares in Q3 2022, an estimated $165K.
Globeflex Capital first reported a position in Medifast in Q2 2013 and held it in 20 quarters.
Globeflex Capital's Medifast position peaked at $1.81M in Q2 2021.
263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Globeflex Capital's 13F filing for Q3 2022, filed 14 Nov 2022.